Since the length of motion of oxycodone could exceed that of the antagonist, the individual ought to be kept beneath ongoing surveillance, and recurring doses in the antagonist ought to be administered as required to maintain suitable respiration. An opioid antagonist shouldn't be administered while in the absence of clinically significant respirat